Status | Study |
Completed |
Study Name: Psychological Concomitants of Morquio Syndrome (The MAP Study) Condition: Morquio Disease Mucopolysaccharidosis IV Date: 2012-12-13 |
Terminated |
Study Name: Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA Condition: Mucopolysaccharidosis Type IVA Date: 2012-11-21 |
Completed |
Study Name: Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease Condition: Mucopolysaccharidosis IV A Mucopolysaccharidosis VI Date: 2012-10-12 Interventions: Other: Enzyme testing Leukocyte activity measurement of Arylsulfatase B and N acetyl galactosamine 6 sul |
Terminated |
Study Name: Efficacy and Safety Study of BMN 110 for Morquio A Syndrome Patients Who Have Limited Ambulation Condition: Mucopolysaccharidosis IVA Morquio A Syndrome MPS IVA Date: 2012-09-17 Interventions: Drug: BMN 110 Drug will be delivered through a 4 hour (approximate) IV infusion at a dosage amount of 2. |
Terminated |
Study Name: Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics Condition: Mucopolysaccharidoses Mucopolysaccharidosis I Mucopolysacc Date: 2012-08-23 Interventions: Other: Dried blood spot test for MPS The dried blood spot test uses a few drops of blood on filter paper |
Terminated |
Study Name: Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome Condition: Mucopolysaccharidosis IVA Morquio A Syndrome MPS IVA Date: 2012-05-24 Interventions: Drug: BMN 110 Weekly IV infusi |
Completed |
Study Name: Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition: Mucopolysaccharidosis IVA Morquio A Syndrome MPS IVA Date: 2011-12-22 Interventions: Drug: BMN 110 Patients will receive intravenous (IV) infusions of study drug at a dose of 2.0 mg/kg/wk o |
Recruiting |
Study Name: Biomarker for Morquio Disease Condition: Lysosomal Storage Diseases Morquio Disease Date: 2011-10-21 |
Completed |
Study Name: Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) Condition: Mucopolysaccharidosis IV A Morquio A Syndrome Date: 2011-08-08 Interventions: Drug: BMN 110 - Weekly |
Recruiting |
Study Name: Longitudinal Studies of Brain Structure and Function in MPS Disorders Condition: Mucopolysaccharidosis Type I Mucopolysaccharidosis Type II Date: 2011-08-02 |